Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic Murine model of Huntington's disease

Journal of Neuroscience

Volumn 21, Issue 23, 2001, Pages 9112-9123

  Laforet, G A ^a   Sapp, E ^a   Chase, K ^a   McIntyre, C ^a   Boyce, F M ^a   Campbell, M ^a   Cadigan, B A ^a   Warzecki, L ^a   Tagle, D A ^a   Reddy, P H ^a   Cepeda, C ^a   Calvert, C R ^a   Jokel, E S ^a   Klapstein, G J ^a   Ariano, M A ^a   Levine, M S ^a   DiFiglia, M ^a   Aronin, N ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Cortex; Huntington's disease; Neuronal morphology; NMDA; Striatum; Transgenic mice

Indexed keywords

GLUTAMINE; HUNTINGTIN; N METHYL DEXTRO ASPARTIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BRAIN CELL; CALCIUM CELL LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE MODEL; ELECTROPHYSIOLOGY; HETEROZYGOTE; HUNTINGTON CHOREA; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0035575858     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-23-09112.2001     Document Type: Article

References (52)

1. Alternative excitotoxic hypotheses
2. + current in pyramidal neurons from rat sensorimotor cortex
3. CAG expansion affects the expression of mutant huntingtin in the Huntington's disease brain
4. Are there multiple pathways in the pathogenesis of Huntington's disease?
5. Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease: An in situ hybridization study
6. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease
7. Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia
8. Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons in slices: Contribution of calcium conductances
9. NMDA receptor hypersensitivity in two models of Huntington's disease
10. Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin
11. Glutamate neurotoxicity and diseases of the nervous system
12. Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations
13. Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea
14. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
15. Excitotoxic injury of the neostriatum: A model for Huntington's disease
16. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
17. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
18. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease
19. Nuclear and neuropil aggregates in Huntington's disease: Relationship to neuropathology
20. Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity
21. Dendritic morphology and its effects on the amplitude and rise-time of synaptic signals in hippocampal CA3 pyramidal cells
22. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration
23. On chorea
24. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
25. Stereology: A practical primer for neuropathology
26. Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy
27. Mutant huntingtin expression in clonal striatal cells: Dissociation of inclusion formation and neuronal survival by caspase inhibition
28. A biotin-containing compound N-(-2-aminoethyl)biotinamide for intracellular labeling and neuronal tracing studies: Comparison with biocytin
29. Electrophysiological and morphological changes in striatal neurons in asymptomatic and symptomatic R6/2 Huntington's disease transgenic mice
30. Huntington's disease gene: Regional and cellular expression in brain of normal and affected individuals
31. Executive and mnemonic functions in early Huntington's disease
32. Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knock-in mouse models of Huntington's disease
33. Neurological abnormalities in a knock-in mouse model of Huntington's disease
34. Influence of dendritic structure on firing pattern in model neocortical neurons
35. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
36. Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids
37. Behavioral abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA
38. Transgenic mice expressing mutated full-length HD cDNA: A paradigm for locomotor changes and selective neuronal loss in Huntington's disease
39. Localization of huntingtin in multivesicular bodies in Huntington's disease
40. Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington's disease
41. Huntingtin acts in the nucleus to induce apoptosis, but death does not correlate with the formation of intranuclear inclusions
42. Evidence of cortical metabolic dysfunction in early Huntington's disease by single-photon-emission computed tomography
43. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin
44. Evidence for neuronal degeneration and dendritic plasticity in cortical pyramidal neurons of Huntington's disease: A quantitative Golgi study
45. Huntington disease
46. Neuropathological classification of Huntington's disease
47. The generalization of Student's problem when several different population variances are involved
48. Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQlll knock-in mice
49. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
50. Mutant huntingtin enhances excitotoxic cell death